T. González

α-Synuclein interferes with the ESCRT-III complex contributing to the pathogenesis of Lewy body disease.

E. Masliah, E. Rockenstein, B. Spencer, 2016, Human molecular genetics.

ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In Vivo

E. Masliah, E. Rockenstein, B. Spencer, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Structural diversity of Alzheimer's disease amyloid-β dimers and their role in oligomerization and fibril formation.

E. Masliah, I. Tsigelny, V. Kouznetsova, 2014, Journal of Alzheimer's disease : JAD.

Role of α‐synuclein penetration into the membrane in the mechanisms of oligomer pore formation

E. Masliah, I. Tsigelny, W. Wrasidlo, 2012, The FEBS journal.

Small molecule NPT-440-1 inhibits ionic flux through Aβ1-42 pores: Implications for Alzheimer's disease therapeutics.

E. Masliah, R. Lal, W. Wrasidlo, 2016, Nanomedicine : nanotechnology, biology, and medicine.

Molecular determinants of α-synuclein mutants' oligomerization and membrane interactions.

E. Masliah, I. Tsigelny, V. Kouznetsova, 2015, ACS chemical neuroscience.

α-Synuclein interferes with the ESCRT-III complex contributing to the pathogenesis of Lewy body disease.

E. Masliah, E. Rockenstein, B. Spencer, 2016, Human molecular genetics.